Cervical carotid revascularization: the role of angioplasty with stenting

2005 ◽  
Vol 16 (2) ◽  
pp. 263-278 ◽  
Author(s):  
Ricardo A. Hanel ◽  
Elad I. Levy ◽  
Lee R. Guterman ◽  
L. Nelson Hopkins
2020 ◽  
pp. 10.1212/CPJ.0000000000000941
Author(s):  
Azam S. Tolla ◽  
Muhammad U. Farooq ◽  
Bradly Haveman-Gould ◽  
Ghassan Naisan ◽  
Philip B. Gorelick

Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are established cerebrovascular procedures to reduce risk of stroke. Complications include stroke, myocardial infarction, and death. A delayed complication following carotid revascularization is cerebral hyperperfusion syndrome (CHS), which can manifest as intracerebral hemorrhage (ICH)[1]. A less common delayed complication of carotid revascularization procedures is reversible cerebral vasoconstriction syndrome (RCVS).


1987 ◽  
Vol 6 (3) ◽  
pp. 280-282 ◽  
Author(s):  
David L. Street ◽  
John J. Ricotta ◽  
Richard M. Green ◽  
James A. DeWeese

Circulation ◽  
2021 ◽  
Author(s):  
Curtis Benesch ◽  
Laurent G. Glance ◽  
Colin P. Derdeyn ◽  
Lee A. Fleisher ◽  
Robert G. Holloway ◽  
...  

Perioperative stroke is a potentially devastating complication in patients undergoing noncardiac, nonneurological surgery. This scientific statement summarizes established risk factors for perioperative stroke, preoperative and intraoperative strategies to mitigate the risk of stroke, suggestions for postoperative assessments, and treatment approaches for minimizing permanent neurological dysfunction in patients who experience a perioperative stroke. The first section focuses on preoperative optimization, including the role of preoperative carotid revascularization in patients with high-grade carotid stenosis and delaying surgery in patients with recent strokes. The second section reviews intraoperative strategies to reduce the risk of stroke, focusing on blood pressure control, perioperative goal-directed therapy, blood transfusion, and anesthetic technique. Finally, this statement presents strategies for the evaluation and treatment of patients with suspected postoperative strokes and, in particular, highlights the value of rapid recognition of strokes and the early use of intravenous thrombolysis and mechanical embolectomy in appropriate patients.


1987 ◽  
Vol 6 (3) ◽  
pp. 280-282 ◽  
Author(s):  
David L. Street ◽  
John J. Ricotta ◽  
Richard M. Green ◽  
James A. DeWeese

2005 ◽  
Vol 27 (sup1) ◽  
pp. 53-58 ◽  
Author(s):  
Christopher J. Koebbe ◽  
Kenneth Liebman ◽  
Erol Veznedaroglu ◽  
Robert Rosenwasser

2020 ◽  
Vol 37 (02) ◽  
pp. 207-213
Author(s):  
Joseph J. Gemmete ◽  
Zachary Wilseck ◽  
Aditya S. Pandey ◽  
Neeraj Chaudhary

AbstractThere is no consensus for the treatment of a tandem occlusion (TO) in a patient presenting with an acute ischemic stroke. In this review article, we will focus on the controversial treatment strategies for TOs. First, we will discuss treatment options including retrograde, antegrade, and delayed approaches. Second, the role of carotid stent placement versus balloon angioplasty for the extracranial occlusion will be presented. Third, anticoagulation and antiplatelet regimens for the treatment TOs published in the literature will be reviewed. Finally, we will discuss whether there is a role for coil occlusion of the cervical carotid artery or whether staged carotid revascularization days after mechanical thrombectomy of the intracranial occlusion maybe appropriate. The optimal treatment strategy of TO has not been established and further larger trials need to be performed to answer the question.


2005 ◽  
Vol 18 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Sunit Das ◽  
Bernard R. Bendok ◽  
Christopher C. Getch ◽  
Issam A. Awad ◽  
H. Hunt Batjer

Stroke remains the leading cause of disability in adults and the third leading cause of death in the US. Carotid artery (CA) occlusive disease is the primary pathophysiological source of 10 to 20% of all strokes. Carotid endarterectomy (CEA) has been shown to reduce the risk of stroke in patients with both symptomatic and asymptomatic extracranial CA stenosis. Carotid artery angioplasty and stent placement has recently emerged as an alternative to CEA for primary and secondary prevention of stroke related to CA stenosis. With the advent of the embolic protection device, the safety of CA angioplasty and stent placement has approached, if not surpassed, that of CEA. In particular, the former has come to be considered as a first-line therapy in the management of CA stenotic disease in individuals at high risk for complications related to surgical intervention. Preliminary data from multiple registries have demonstrated that CA angioplasty and stent placement is an effective means of treating CA stenosis. The results of the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy trial have demonstrated that this modality has a significant role in the management of CA disease in symptomatic and asymptomatic patients with risk factors for high rates of surgery-related morbidity or mortality. With the completion of the Carotid Revascularization Endarterectomy versus Stent Trial, the role of CA angioplasty and stent placement in the prevention of stroke in all individuals with significant CA stenosis should be better demarcated. This treatment modality promises to assume a central role in stroke prophylaxis in patients with CA disease who are at high risk for complications related to surgery.


2021 ◽  
Vol 74 (3) ◽  
pp. e33-e34
Author(s):  
Nadin Elsayed ◽  
Isaac Naazie ◽  
Jonathan Unkart ◽  
Peter F. Lawrence ◽  
Mahmoud B. Malas

Sign in / Sign up

Export Citation Format

Share Document